vs
Amarin Corp plc（AMRN）与ORRSTOWN FINANCIAL SERVICES INC（ORRF）财务数据对比。点击上方公司名可切换其他公司
ORRSTOWN FINANCIAL SERVICES INC的季度营收约是Amarin Corp plc的1.4倍（$64.6M vs $45.1M），ORRSTOWN FINANCIAL SERVICES INC净利率更高（33.8% vs -23.3%，领先57.1%），过去两年ORRSTOWN FINANCIAL SERVICES INC的营收复合增速更高（39.3% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
奥尔斯敦金融服务公司是总部位于美国宾夕法尼亚州的区域性银行控股企业，提供零售及商业银行服务，涵盖存款账户、个人与企业贷款、按揭产品、财富管理等业务，主要服务宾州中部及马里兰州北部的个人客户和中小微企业。
AMRN vs ORRF — 直观对比
营收规模更大
ORRF
是对方的1.4倍
$45.1M
净利率更高
ORRF
高出57.1%
-23.3%
两年增速更快
ORRF
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $64.6M |
| 净利润 | $-10.5M | $21.8M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | — |
| 净利率 | -23.3% | 33.8% |
| 营收同比 | 7.0% | — |
| 净利润同比 | 33.0% | 19.1% |
| 每股收益（稀释后） | — | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNORRF
| Q1 26 | $45.1M | $64.6M | ||
| Q4 25 | $49.2M | $64.9M | ||
| Q3 25 | $49.7M | $64.4M | ||
| Q2 25 | $72.7M | $62.4M | ||
| Q1 25 | $42.0M | $60.4M | ||
| Q4 24 | $62.3M | $61.8M | ||
| Q3 24 | $42.3M | $64.1M | ||
| Q2 24 | $67.5M | $33.3M |
净利润AMRNORRF
| Q1 26 | $-10.5M | $21.8M | ||
| Q4 25 | $-1.2M | $21.5M | ||
| Q3 25 | $-7.7M | $21.9M | ||
| Q2 25 | $-14.1M | $19.4M | ||
| Q1 25 | $-15.7M | $18.1M | ||
| Q4 24 | $-48.6M | $13.7M | ||
| Q3 24 | $-25.1M | $-7.9M | ||
| Q2 24 | $1.5M | $7.7M |
毛利率AMRNORRF
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNORRF
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 42.3% | ||
| Q3 25 | -22.4% | 43.0% | ||
| Q2 25 | -22.0% | 39.6% | ||
| Q1 25 | -39.9% | 37.7% | ||
| Q4 24 | -84.3% | 27.7% | ||
| Q3 24 | -59.5% | -15.4% | ||
| Q2 24 | -0.8% | 29.5% |
净利率AMRNORRF
| Q1 26 | -23.3% | 33.8% | ||
| Q4 25 | -2.5% | 33.1% | ||
| Q3 25 | -15.6% | 34.0% | ||
| Q2 25 | -19.4% | 31.2% | ||
| Q1 25 | -37.4% | 29.9% | ||
| Q4 24 | -78.0% | 22.1% | ||
| Q3 24 | -59.4% | -12.3% | ||
| Q2 24 | 2.3% | 23.3% |
每股收益（稀释后）AMRNORRF
| Q1 26 | — | $1.12 | ||
| Q4 25 | $0.00 | $1.11 | ||
| Q3 25 | $-0.02 | $1.13 | ||
| Q2 25 | $-0.03 | $1.01 | ||
| Q1 25 | $-0.04 | $0.93 | ||
| Q4 24 | $-0.12 | $0.35 | ||
| Q3 24 | $-0.06 | $-0.41 | ||
| Q2 24 | $0.00 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $161.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $603.2M |
| 总资产 | $645.8M | $5.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNORRF
| Q1 26 | $307.8M | $161.8M | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | — | ||
| Q2 25 | $298.7M | — | ||
| Q1 25 | $281.8M | — | ||
| Q4 24 | $294.2M | — | ||
| Q3 24 | $305.7M | — | ||
| Q2 24 | $306.7M | — |
股东权益AMRNORRF
| Q1 26 | — | $603.2M | ||
| Q4 25 | $459.3M | $591.5M | ||
| Q3 25 | $458.9M | $571.9M | ||
| Q2 25 | $464.9M | $548.4M | ||
| Q1 25 | $473.7M | $532.9M | ||
| Q4 24 | $486.2M | $516.7M | ||
| Q3 24 | $531.4M | $516.2M | ||
| Q2 24 | $551.9M | $278.4M |
总资产AMRNORRF
| Q1 26 | $645.8M | $5.6B | ||
| Q4 25 | $670.8M | $5.5B | ||
| Q3 25 | $659.8M | $5.5B | ||
| Q2 25 | $670.1M | $5.4B | ||
| Q1 25 | $655.7M | $5.4B | ||
| Q4 24 | $685.3M | $5.4B | ||
| Q3 24 | $750.6M | $5.5B | ||
| Q2 24 | $799.9M | $3.2B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
ORRF
| Net Interest Income | $49.0M | 76% |
| Noninterest Income | $15.6M | 24% |
